-
2021Differential levels of IFNα subtypes in autoimmunity and viral infection., Cytokine 2021 Aug; 144(): 155533.
-
2019Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumor growth, Nat. Immunol. 2019 Mar;20(3):257-264.
-
2018Development and clinical validation of the Genedrive point-of-care test for qualitative detection of hepatitis C virus., Gut 2018 Nov; 67(11): 2017-2024.
-
2017An in vitro diagnostic certified point of care single nucleotide test for IL28B polymorphisms, PLoS ONE 2017;12(9):e0183084.
-
2017Hepatitis E virus-induced primary cutaneous CD30(+) T cell lymphoproliferative disorder., J. Hepatol. 2017 12; 67(6): 1334-1339.
-
2016Immunological and Antiviral Responses After Therapeutic DNA Immunization in Chronic Hepatitis B Patients Efficiently Treated by Analogues, Mol. Ther. 2014 Mar;22(3):675-684.
-
2016HCVerso1 and 2: faldaprevir with deleobuvir (BI 207127) and ribavirin for treatment-naïve patients with chronic hepatitis C virus genotype-1b infection, Clin Exp Gastroenterol 2016;9:351-363.
-
2016Treatment With Ledipasvir-Sofosbuvir for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic Hepatitis C Virus Genotype 1 or 4 Infection: A Randomized Trial, Ann. Intern. Med. 2017 Jan;166(2):109-117.
-
2016Hepatitis B virus reactivation in patients with solid tumors receiving systemic anticancer treatment, Ann. Oncol. 2016 Dec;27(12):2172-2184.
-
2016Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication, J. Hepatol. 2016 Oct;.
-
2016Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study, PLoS ONE 2016;11(10):e0162965.
-
2016Glutathione conjugation dose-dependently increases brain-specific liposomal drug delivery in vitro and in vivo, Drug Discov Today Technol 2016 Jun;20:59-69.
-
2016Diagnostic accuracy of des-gamma-carboxy prothrombin for hepatocellular carcinoma in a French cohort using the Lumipulse(®) G600 analyzer, J. Viral Hepat. 2017 Jan;24(1):80-85.
-
2016Is stronger better in curing hepatitis C virus infection?, Ann Transl Med 2016 Oct;4(19):386.
-
2016Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications, Gastroenterology 2017 Jan;152(1):142-156.e2.
-
2016Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients, J. Hepatol. 2017 Jan;66(1):39-47.
-
2016Protandim Protects Oligodendrocytes against an Oxidative Insult, Antioxidants (Basel) 2016 Sep;5(3).
-
2016Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection, Blood 2016 Nov;128(21):2527-2532.
-
2016BRIP1 coding variants are associated with a high risk of hepatocellular carcinoma occurrence in patients with HCV- or HBV-related liver disease, Oncotarget 2016 Aug;.
-
2016Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen, BMC Infect. Dis. 2016 Aug;16:393.
-
2016Nomogram for individualized prediction of hepatocellular carcinoma occurrence in hepatitis C virus cirrhosis (ANRS CO12 CirVir), Hepatology 2016 Oct;64(4):1136-47.
-
2016High Prevalence of Antimicrobial-resistant Gram-negative Colonization in Hospitalized Cambodian Infants, Pediatr. Infect. Dis. J. 2016 Aug;35(8):856-61.
-
2016A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patients, Hepatology 2016 Nov;64(5):1462-1472.
-
2016Reply to “A strong message is needed to address the issue of HCC recurrence after DAA therapy”, J. Hepatol. 2016 Dec;65(6):1269-1270.
-
2016Anti-hepatitis C virus potency of a new autophagy inhibitor using human liver slices model, World J Hepatol 2016 Jul;8(21):902-14.
-
2016Neuroendothelial NMDA receptors as therapeutic targets in experimental autoimmune encephalomyelitis, Brain 2016 Sep;139(Pt 9):2406-19.
-
2016The relationship between liver stiffness measurement and outcome in patients with chronic hepatitis C and cirrhosis: a retrospective longitudinal hospital study, Aliment. Pharmacol. Ther. 2016 Sep;44(5):505-13.
-
2016Daclatasvir/peginterferon lambda-1a/ribavirin in patients with chronic HCV infection and haemophilia who are treatment naïve or prior relapsers to peginterferon alfa-2a/ribavirin, Haemophilia 2016 Sep;22(5):692-9.
-
2016Internalization and presentation of myelin antigens by the brain endothelium guides antigen-specific T cell migration, Elife 2016 Jun;5.
-
2016In Situ Hepatitis C NS3 Protein Detection Is Associated with High Grade Features in Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas, PLoS ONE 2016;11(6):e0156384.
-
2016Cost-effectiveness and budget impact of interferon-free direct-acting antiviral-based regimens for hepatitis C treatment: the French case, J. Viral Hepat. 2016 Oct;23(10):767-79.
-
2016Human endogenous retrovirus W in brain lesions: Rationale for targeted therapy in multiple sclerosis, Mult Scler Relat Disord 2016 Jul;8:11-8.
-
2016Comprehensive review of telbivudine in pregnant women with chronic hepatitis B, World J Hepatol 2016 Mar;8(9):452-60.
-
2016An update on the management of hepatitis C virus-infected patients with stage 4-5 chronic kidney disease while awaiting the revised KDIGO Guidelines, Nephrol. Dial. Transplant. 2016 Mar;.
-
2016Targeting human oligodendrocyte progenitors for myelin repair, Exp. Neurol. 2016 Sep;283(Pt B):489-500.
-
2016Daclatasvir-sofosbuvir combination therapy with or without ribavirin for hepatitis C virus infection: from the clinical trials to real life, Hepat Med 2016;8:21-6.
-
2016Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY-3+), Hepatology 2016 May;63(5):1430-41.
-
2016Development and internal validation of a multivariable prediction model for biochemical failure after whole-gland salvage iodine-125 prostate brachytherapy for recurrent prostate cancer, Brachytherapy 2016 May-Jun;15(3):296-305.
-
2016Impact of Obliterative Portal Venopathy Associated With Human Immunodeficiency Virus, Medicine (Baltimore) 2016 Mar;95(11):e3081.
-
2016Transmission of Hepatitis E Virus by Plasma Exchange: A Case Report, Ann. Intern. Med. 2016 Jun;164(12):851-2.
-
2016Is hardship during migration a determinant of HIV infection? Results from the ANRS PARCOURS study of sub-Saharan African migrants in France, AIDS 2016 Feb;30(4):645-56.
-
2016Multivariable model development and internal validation for prostate cancer specific survival and overall survival after whole-gland salvage Iodine-125 prostate brachytherapy, Radiother Oncol 2016 04;119(1):104-10.
-
2016Mycobacterium avium complex disseminated infection in a kidney transplant recipient, Transpl Infect Dis 2016 Feb;18(1):105-11.
-
2016Idiopathic gingival fibromatosis with asymmetrical presentation and electrosurgical management, J Indian Soc Periodontol 2016 Jan-Feb;20(1):98-102.
-
2016HCV and the kidney, Liver Int. 2016 Jan;36 Suppl 1:28-33.
-
2015Protective effects of monomethyl fumarate at the inflamed blood-brain barrier, Microvasc. Res. 2016 May;105:61-9.
-
2015Differential expression of glucose-metabolizing enzymes in multiple sclerosis lesions, Acta Neuropathol Commun 2015 Dec;3:79.
-
2015Acid Sphingomyelinase-Derived Ceramide Regulates ICAM-1 Function during T Cell Transmigration across Brain Endothelial Cells, J. Immunol. 2016 Jan;196(1):72-9.
-
2015Rectal dose constraints for salvage iodine-125 prostate brachytherapy, Brachytherapy 2016 Jan-Feb;15(1):85-93.
-
2015Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection, N. Engl. J. Med. 2015 Dec;373(27):2608-17.
-
2015Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection, N. Engl. J. Med. 2015 Dec;373(27):2599-607.
-
2015Sofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinaemia vasculitis: VASCUVALDIC study, Ann. Rheum. Dis. 2016 Oct;75(10):1777-82.
-
2015Bradyarrhythmias Associated with Sofosbuvir Treatment, N. Engl. J. Med. 2015 Nov;373(19):1886-8.
-
2015Hepatitis C virus treatment in the real world: optimising treatment and access to therapies, Gut 2015 Nov;64(11):1824-33.
-
2015Bacterial infection in compensated viral cirrhosis impairs 5-year survival (ANRS CO12 CirVir prospective cohort), Gut 2017 Feb;66(2):330-341.
-
2015Daclatasvir plus simeprevir with or without ribavirin for the treatment of chronic hepatitis C virus genotype 1 infection, J. Hepatol. 2016 Feb;64(2):292-300.
-
2015Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 study, Lancet 2015 Oct;386(10003):1537-45.
-
2015[Management of hepatitis B virus and hepatitis C virus infection in chronic kidney failure], Nephrol. Ther. 2015 Nov;11(6):507-20.
-
2015Portal hypertension in patients with cirrhosis: indirect assessment of hepatic venous pressure gradient by measuring azygos flow with 2D-cine phase-contrast magnetic resonance imaging, Eur Radiol 2016 Jul;26(7):1981-90.
-
2015Acceptance and commitment therapy group-treatment for non-responsive patients with personality disorders: An exploratory study, Personal Ment Health 2015 Nov;9(4):345-56.
-
2015[Treatment of chronic hepatitis B virus infection and hepatocellular carcinoma prevention], Presse Med 2015 Dec;44(12 Pt 1):1251-5.
-
2015Urethral and bladder dosimetry of total and focal salvage Iodine-125 prostate brachytherapy: Late toxicity and dose constraints, Radiother Oncol 2015 Nov;117(2):262-9.
-
2015Patient and physician preferences for the treatment of chronic hepatitis C virus infections: does the perspective matter?, Eur J Gastroenterol Hepatol 2015 Sep;27(9):1063-8.
-
2015Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial, Lancet Infect Dis 2015 Nov;15(11):1283-91.
-
2015Enhanced microglial pro-inflammatory response to lipopolysaccharide correlates with brain infiltration and blood-brain barrier dysregulation in a mouse model of telomere shortening, Aging Cell 2015 Dec;14(6):1003-13.
-
2015The CUPIC algorithm: an accurate model for the prediction of sustained viral response under telaprevir or boceprevir triple therapy in cirrhotic patients, J. Viral Hepat. 2015 Dec;22(12):1002-10.
-
2015Trichuris suis induces human non-classical patrolling monocytes via the mannose receptor and PKC: implications for multiple sclerosis, Acta Neuropathol Commun 2015 Jul;3:45.
-
2015Tissue Transglutaminase contributes to experimental multiple sclerosis pathogenesis and clinical outcome by promoting macrophage migration, Brain Behav. Immun. 2015 Nov;50:141-54.
-
2015The impact of ledipasvir/sofosbuvir on patient-reported outcomes in cirrhotic patients with chronic hepatitis C: the SIRIUS study, Liver Int. 2016 Jan;36(1):42-8.
-
2015Patients with chronic hepatitis B should be screened for hepatocellular carcinoma regardless of liver stiffness measurement, Hepatology 2016 Feb;63(2):672.
-
2015Sofosbuvir plus pegylated interferon and ribavirin in patients with genotype 1 hepatitis C virus in whom previous therapy with direct-acting antivirals has failed, Hepatology 2015 Jul;62(1):129-34.
-
2015Vitamin D in addition to peg-interferon-alpha/ribavirin in chronic hepatitis C virus infection: ANRS-HC25-VITAVIC study, World J. Gastroenterol. 2015 May;21(18):5647-53.
-
2015Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis, Hepatology 2015 Jul;62(1):79-86.
-
2015Fixed-dose combination therapy with daclatasvir, asunaprevir, and beclabuvir for noncirrhotic patients with HCV genotype 1 infection, JAMA 2015 May;313(17):1728-35.
-
2015Regression of an HCV-associated disseminated marginal zone lymphoma under IFN-free antiviral treatment, Blood 2015 Apr;125(15):2446-7.
-
2015Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial, Lancet 2015 Jun;385(9986):2502-9.
-
2015Soluble VCAM-1 impairs human brain endothelial barrier integrity via integrin α-4-transduced outside-in signalling, Acta Neuropathol. 2015 May;129(5):639-52.
-
2015Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort), Hepatology 2015 Sep;62(3):737-50.
-
2015Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS), Lancet Infect Dis 2015 Apr;15(4):397-404.
-
2015Anti-muscarinic adjunct therapy accelerates functional human oligodendrocyte repair, J. Neurosci. 2015 Feb;35(8):3676-88.
-
2015Long-term stability and temporal trends of organic contaminants in four collections of mussel tissue frozen standard reference materials, Anal Bioanal Chem 2015 Apr;407(11):3253-8.
-
2015Daclatasvir and asunaprevir plus peginterferon alfa and ribavirin in HCV genotype 1 or 4 non-responders, J. Hepatol. 2015 Jul;63(1):30-7.
-
2015Hepatitis: HBV vaccine–the first vaccine to prevent cancer, Nat Rev Gastroenterol Hepatol 2015 Apr;12(4):190-1.
-
2015Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors-based therapy, Liver Int. 2015 Jul;35(7):1833-44.
-
2015IL-15 amplifies the pathogenic properties of CD4+CD28- T cells in multiple sclerosis, J. Immunol. 2015 Mar;194(5):2099-109.
-
2015Therapeutic management and evolution of chronic hepatitis B: does HIV still have an impact? The EPIB 2012 study, Liver Int. 2015 Aug;35(8):1950-8.
-
2015Telaprevir enhances ribavirin-induced anaemia through renal function impairment, Antivir. Ther. (Lond.) 2015;20(5):479-86.
-
2014Brain endothelial miR-146a negatively modulates T-cell adhesion through repressing multiple targets to inhibit NF-κB activation, J. Cereb. Blood Flow Metab. 2015 Mar;35(3):412-23.
-
2014Therapeutic vaccines in treating chronic hepatitis B: the end of the beginning or the beginning of the end?, Med. Microbiol. Immunol. 2015 Feb;204(1):121-9.
-
2014Astroglial PGC-1alpha increases mitochondrial antioxidant capacity and suppresses inflammation: implications for multiple sclerosis, Acta Neuropathol Commun 2014 Dec;2:170.
-
2014Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study, Am. J. Hematol. 2015 Mar;90(3):197-203.
-
2014Effect of nucleoside and nucleotide analogues on renal function in patients with chronic hepatitis B virus monoinfection, Clin. Gastroenterol. Hepatol. 2015 Jun;13(6):1181-8.e1.
-
2014Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon-based therapy: FUNDAMENTAL, a Phase II trial, J. Viral Hepat. 2015 Jul;22(7):596-606.
-
2014Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C virus genotype 1 mono-infection and HIV/hepatitis C virus co-infection (C-WORTHY): a randomised, open-label phase 2 trial, Lancet 2015 Mar;385(9973):1087-97.
-
2014Low-density lipoprotein and other predictors of response with telaprevir-based therapy in treatment-experienced HCV genotype 1 patients: REALIZE study, Liver Int. 2015 Feb;35(2):448-54.
-
2014Baseline sensitivity of T cells to alpha-IFN correlates with sustained virological response to IFN-based triple therapy in HCV infection, J. Viral Hepat. 2015 Jun;22(6):524-34.
-
2014Persistence to Treatment of Chronic Hepatitis B Virus (Hbv) Infection: A Study Based on the French Ims Lifelink Treatment Dynamics (LTD) Database, Value Health 2014 Nov;17(7):A681.
-
2014Urinary antibiotic activity in paediatric patients attending an outpatient department in north-western Cambodia, Trop. Med. Int. Health 2015 Jan;20(1):24-8.
-
2014Daclatasvir plus peginterferon and ribavirin is noninferior to peginterferon and ribavirin alone, and reduces the duration of treatment for HCV genotype 2 or 3 infection, Gastroenterology 2015 Feb;148(2):355-366.e1.
-
2014Apolipoprotein H expression is associated with IL28B genotype and viral clearance in hepatitis C virus infection., J. Hepatol. 2014 Oct; 61(4): 770-6.
-
2014Investigating liver stiffness and viscosity for fibrosis, steatosis and activity staging using shear wave elastography, J. Hepatol. 2015 Feb;62(2):317-24.
-
2014Randomized study of danoprevir/ritonavir-based therapy for HCV genotype 1 patients with prior partial or null responses to peginterferon/ribavirin, J. Hepatol. 2015 Feb;62(2):294-302.
-
2014Impact of common risk factors of fibrosis progression in chronic hepatitis C, Gut 2015 Oct;64(10):1605-15.
-
2014Dermatological side-effects in hepatitis C infected patients under a triple regimen associating pegylated interferon, ribavirin and telaprevir, J Eur Acad Dermatol Venereol 2016 Jan;30(1):143-6.
-
2014Treatment of hepatitis C: perspectives, Med Mal Infect 2014 Oct;44(10):449-54.
-
2014Astrocyte-derived retinoic acid: a novel regulator of blood-brain barrier function in multiple sclerosis, Acta Neuropathol. 2014 Nov;128(5):691-703.
-
2014Telaprevir for HIV/hepatitis C virus-coinfected patients failing treatment with pegylated interferon/ribavirin (ANRS HC26 TelapreVIH): an open-label, single-arm, phase 2 trial, Clin. Infect. Dis. 2014 Dec;59(12):1768-76.
-
2014PegIFNα/ribavirin/protease inhibitor combination in severe hepatitis C virus-associated mixed cryoglobulinemia vasculitis, J. Hepatol. 2015 Jan;62(1):24-30.
-
2014Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study, Gut 2015 Jun;64(6):948-56.
-
2014All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study, Lancet 2014 Nov;384(9954):1597-605.
-
2014Randomized trial of asunaprevir plus peginterferon alfa and ribavirin for previously untreated genotype 1 or 4 chronic hepatitis C, J. Hepatol. 2014 Dec;61(6):1220-7.
-
2014Hepatitis B virus treatment beyond the guidelines: special populations and consideration of treatment withdrawal, Therap Adv Gastroenterol 2014 Jul;7(4):148-55.
-
2014Transcription factor induction of human oligodendrocyte progenitor fate and differentiation, Proc. Natl. Acad. Sci. U.S.A. 2014 Jul;111(28):E2885-94.
-
2014Role of a 48-week pegylated interferon therapy in hepatitis B e antigen positive HIV-co-infected patients on cART including tenofovir: EMVIPEG study, J. Hepatol. 2014 Oct;61(4):761-9.
-
2014All-oral combination of ledipasvir, vedroprevir, tegobuvir, and ribavirin in treatment-naïve patients with genotype 1 HCV infection, Hepatology 2014 Jul;60(1):56-64.
-
2014Sofosbuvir and ribavirin in HCV genotypes 2 and 3, N. Engl. J. Med. 2014 May;370(21):1993-2001.
-
2014[Treatment of hepatitis C: current status and perspectives], Rev Prat 2014 May;64(5):605-12.
-
2014In vivo MR imaging of intercellular adhesion molecule-1 expression in an animal model of multiple sclerosis, Contrast Media Mol Imaging 2015 Mar-Apr;10(2):111-21.
-
2014Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis, Gastroenterology 2014 Jul;147(1):132-142.e4.
-
2014Cellular distribution of glucose and monocarboxylate transporters in human brain white matter and multiple sclerosis lesions, Glia 2014 Jul;62(7):1125-41.
-
2014Ribavirin for chronic hepatitis E virus infection in transplant recipients, N. Engl. J. Med. 2014 Mar;370(12):1111-20.
-
2014Up-regulation of the ATP-binding cassette transporter A1 inhibits hepatitis C virus infection, PLoS ONE 2014;9(3):e92140.
-
2014Should we await IFN-free regimens to treat HCV genotype 1 treatment-naive patients? A cost-effectiveness analysis (ANRS 95141), J. Hepatol. 2014 Jul;61(1):7-14.
-
2014Prevalence of renal abnormalities in chronic HBV infection: the HARPE study, Liver Int. 2015 Jan;35(1):148-55.
-
2014Anti-HBV DNA vaccination does not prevent relapse after discontinuation of analogues in the treatment of chronic hepatitis B: a randomised trial–ANRS HB02 VAC-ADN, Gut 2015 Jan;64(1):139-47.
-
2014Effectiveness and cost-effectiveness of immediate versus delayed treatment of hepatitis C virus-infected patients in a country with limited resources: the case of Egypt, Clin. Infect. Dis. 2014 Apr;58(8):1064-71.
-
2014Biologic targeted therapies in pediatric rheumatology, Joint Bone Spine 2014 Feb;81 Suppl 1:2-48.
-
2014Treatment of hepatitis C virus genotype 3-infection, Liver Int. 2014 Feb;34 Suppl 1:18-23.
-
2014P-glycoprotein regulates trafficking of CD8(+) T cells to the brain parenchyma, Acta Neuropathol. 2014 May;127(5):699-711.
-
2013Re-treatment of chronic HCV infection in HIV co-infected patients and predictors of sustained viral response, J. Infect. 2014 May;68(5):462-6.
-
2013Disturbed function of the blood-cerebrospinal fluid barrier aggravates neuro-inflammation, Acta Neuropathol. 2014 Aug;128(2):267-77.
-
2013Predictors associated with treatment initiation and switch in a real-world chronic hepatitis B population from five European countries, J. Viral Hepat. 2014;21(9):662-70.
-
2013Immunological and antiviral responses after therapeutic DNA immunization in chronic hepatitis B patients efficiently treated by analogues, Mol. Ther. 2014 Mar;22(3):675-84.
-
2013Use of first-generation HCV protease inhibitors in patients coinfected by HIV and HCV genotype 1, Liver Int. 2014 Jul;34(6):869-89.
-
2013[Hepatitis C virus: 25 years-old, the end?], Med Sci (Paris) 2013 Nov;29(11):998-1003.
-
2013[Epidemiology, transmission and screening of viral hepatitis], Soins 2013 Nov;(780):24-7.
-
2013[Viral hepatitis, diagnosis, natural history and treatment], Soins 2013 Nov;(780):20-3.
-
2013Efficacy of an interferon- and ribavirin-free regimen of daclatasvir, asunaprevir, and BMS-791325 in treatment-naive patients with HCV genotype 1 infection, Gastroenterology 2014 Feb;146(2):420-9.
-
2013Randomized trial of daclatasvir and asunaprevir with or without PegIFN/RBV for hepatitis C virus genotype 1 null responders, J. Hepatol. 2014 Mar;60(3):490-9.
-
2013Homeostasis model assessment of insulin resistance does not seem to predict response to telaprevir in chronic hepatitis C in the REALIZE trial, Hepatology 2013 Dec;58(6):1897-906.
-
2013[Prognosis assessment of alcoholic liver disease: how and why?], Presse Med 2014 Feb;43(2):124-34.
-
2013Improved fibrosis staging by elastometry and blood test in chronic hepatitis C, Liver Int. 2014 Jul;34(6):907-17.
-
2013ATP-binding cassette transporters P-glycoprotein and breast cancer related protein are reduced in capillary cerebral amyloid angiopathy, Neurobiol. Aging 2014 Mar;35(3):565-75.
-
2013HCV, ribavirin, and anemia: a new dawn, Gastroenterology 2013 Nov;145(5):930-3.
-
2013Roles for HB-EGF and CD9 in multiple sclerosis, Glia 2013 Nov;61(11):1890-905.
-
2013Kinetic profiles and management of hepatitis B virus reactivation in patients with immune-mediated inflammatory diseases, Arthritis Care Res (Hoboken) 2013 Sep;65(9):1504-14.
-
2013Hepatitis C virus infection in hemodialysis patients, Clin Res Hepatol Gastroenterol 2013 Sep;37(4):340-6.
-
2013AST/ALT ratio is not an index of liver fibrosis in chronic hepatitis C when aminotransferase activities are determinate according to the international recommendations, Clin Res Hepatol Gastroenterol 2013 Nov;37(5):467-72.
-
2013Viral hepatitis and the kidney, Clin Res Hepatol Gastroenterol 2013 Sep;37(4):313.
-
2013Randomized study of asunaprevir plus pegylated interferon-α and ribavirin for previously untreated genotype 1 chronic hepatitis C, Antivir. Ther. (Lond.) 2013;18(7):885-93.
-
2013PROPEL: a randomized trial of mericitabine plus peginterferon alpha-2a/ribavirin therapy in treatment-naïve HCV genotype 1/4 patients, Hepatology 2013 Aug;58(2):524-37.
-
2013Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial, Lancet Infect Dis 2013 Jul;13(7):597-605.
-
2013Preexposure prophylaxis (PrEP) of HIV infection in France: a nationwide cross-sectional study (PREVIC study), AIDS Care 2014 Feb;26(2):176-85.
-
2013Rapid progression of antiviral treatments of chronic hepatitis C virus infection, Minerva Gastroenterol Dietol 2013 Jun;59(2):161-72.
-
2013Oral antiviral therapies for chronic hepatitis C infection, Ther Adv Infect Dis 2013 Jun;1(3):107-16.
-
2013Faldaprevir combined with peginterferon alfa-2a and ribavirin in chronic hepatitis C virus genotype-1 patients with prior nonresponse: SILEN-C2 trial, Hepatology 2013 Jun;57(6):2155-63.
-
2013Precise evaluation of liver histology by computerized morphometry shows that steatosis influences liver stiffness measured by transient elastography in chronic hepatitis C, J. Gastroenterol. 2014 Mar;49(3):527-37.
-
2013Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) – NCT01514890, J. Hepatol. 2013 Sep;59(3):434-41.
-
2013CD133/CD140a-based isolation of distinct human multipotent neural progenitor cells and oligodendrocyte progenitor cells, Stem Cells Dev. 2013 Aug;22(15):2121-31.
-
2013Peg-IFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24, Ann. Rheum. Dis. 2014 May;73(5):831-7.
-
2013Chronic hepatitis B treatment initiation and modification patterns in five European countries: a 2-year longitudinal, non-interventional study, Antivir. Ther. (Lond.) 2014;19(3):235-43.
-
2013Faldaprevir (BI 201335), deleobuvir (BI 207127) and ribavirin oral therapy for treatment-naive HCV genotype 1: SOUND-C1 final results, Antivir. Ther. (Lond.) 2013;18(8):1015-9.
-
2013Management of hepatitis C virus infection in heavy drinkers, Alcohol Alcohol. 2013 May-Jun;48(3):337-42.
-
2013Sox10-MCS5 enhancer dynamically tracks human oligodendrocyte progenitor fate, Exp. Neurol. 2013 Sep;247:694-702.
-
2013Extended use of dabigatran, warfarin, or placebo in venous thromboembolism, N. Engl. J. Med. 2013 Feb;368(8):709-18.
-
2013Determination of reliability criteria for liver stiffness evaluation by transient elastography, Hepatology 2013 Mar;57(3):1182-91.
-
2013Management of HBV in immunocompromised patients, Liver Int. 2013 Feb;33 Suppl 1:182-7.
-
2013How to optimize HCV therapy in genotype 1 patients with cirrhosis, Liver Int. 2013 Feb;33 Suppl 1:46-55.
-
2013Limited impact of IL28B genotype on response rates in telaprevir-treated patients with prior treatment failure, J. Hepatol. 2013 May;58(5):883-9.
-
2012Reply to: “Further evidence of the benefits associated with antiviral treatment in kidney allograft recipients with chronic hepatitis B virus infection”, J. Hepatol. 2013 Apr;58(4):835.
-
2012Sustained virologic response rates with telaprevir by response after 4 weeks of lead-in therapy in patients with prior treatment failure, J. Hepatol. 2013 Mar;58(3):488-94.
-
2012Clinical management of drug-drug interactions in HCV therapy: challenges and solutions, J. Hepatol. 2013 Apr;58(4):792-800.
-
2012Including osteoprotegerin and collagen IV in a score-based blood test for liver fibrosis increases diagnostic accuracy, Clin. Chim. Acta 2013 Jan;415:63-8.
-
2012Hepatitis: HCV virologic response–new nomenclature recommendations, Nat Rev Gastroenterol Hepatol 2012 Nov;9(11):619-20.
-
2012Histone deacetylase activity is required for human oligodendrocyte progenitor differentiation, Glia 2012 Dec;60(12):1944-53.
-
2012Protease inhibitor-based triple therapy in chronic hepatitis C: guidelines by the French Association for the Study of the Liver, Liver Int. 2012 Nov;32(10):1477-92.
-
2012Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection, Gastroenterology 2012 Nov;143(5):1244-52.e1-12.
-
2012Efficient replication of primary or culture hepatitis C virus isolates in human liver slices: a relevant ex vivo model of liver infection, Hepatology 2012 Sep;56(3):861-72.
-
2012Nonalcoholic fatty liver disease and HIV infection, Semin. Liver Dis. 2012 May;32(2):158-66.
-
2012Clusters of activated microglia in normal-appearing white matter show signs of innate immune activation, J Neuroinflammation 2012 Jul;9:156.
-
2012Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation, J Control Release 2012 Dec;164(3):364-9.
-
2012Sphingosine 1-phosphate receptor 5 mediates the immune quiescence of the human brain endothelial barrier, J Neuroinflammation 2012 Jun;9:133.
-
2012Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial, Lancet Infect Dis 2012 Sep;12(9):671-7.
-
2012Production of hepatitis B defective particles is dependent on liver status, Virology 2012 Sep 15-30;431(1-2):21-8.
-
2012Hepatitis e virus infection in sheltered homeless persons, france, Emerging Infect. Dis. 2012 Jun;18(6):1031; author reply 1032.
-
2012Severe skin rash in case of readministration of telaprevir in a patient who previously experienced a non severe rash, Hepatology 2012 Jun;55(6):2042-3.
-
2012Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinoma, PLoS ONE 2012;7(5):e37563.
-
2012Factors that predict response of patients with hepatitis C virus infection to boceprevir, Gastroenterology 2012 Sep;143(3):608-18.e1-5.
-
2012Nanoclusters of iron oxide: effect of core composition on structure, biocompatibility, and cell labeling efficacy, Bioconjug. Chem. 2012 May;23(5):941-50.
-
2012T-cell responses to hepatitis B splice-generated protein of hepatitis B virus and inflammatory cytokines/chemokines in chronic hepatitis B patients. ANRS study: HB EP 02 HBSP-FIBRO, J. Viral Hepat. 2012 Dec;19(12):872-80.
-
2012Soluble helminth products suppress clinical signs in murine experimental autoimmune encephalomyelitis and differentially modulate human dendritic cell activation, Mol. Immunol. 2012 Jun;51(2):210-8.
-
2012First-line treatment of chronic hepatitis B with entecavir or tenofovir in ‘real-life’ settings: from clinical trials to clinical practice, J. Viral Hepat. 2012 Jun;19(6):377-86.
-
2012Hepatitis C virus-specific cellular immune responses in individuals with no evidence of infection, Virol. J. 2012 Mar;9:76.
-
2012EASL clinical practice guidelines: Management of chronic hepatitis B virus infection, J. Hepatol. 2012 Jul;57(1):167-85.
-
2012Gemcitabine and oxaliplatin as second-line treatment in patients with hepatocellular carcinoma pre-treated with sorafenib, Med. Oncol. 2012 Dec;29(4):2793-9.
-
2012[Alcoholic hepatitis], Rev Med Interne 2012 Jun;33(6):311-7.
-
2012Benefits associated with antiviral treatment in kidney allograft recipients with chronic hepatitis B virus infection, J. Hepatol. 2012 Jul;57(1):55-60.
-
2012Rapid decline of liver stiffness following alcohol withdrawal in heavy drinkers, Alcohol. Clin. Exp. Res. 2012 Aug;36(8):1407-11.
-
2012IL28B genetic polymorphism testing in the era of direct acting antivirals therapy for chronic hepatitis C: ten years too late?, Liver Int. 2012 Feb;32 Suppl 1:74-8.
-
2012Hepatitis C: epidemiology, diagnosis, natural history and therapy, Contrib Nephrol 2012;176:1-9.
-
2012Dietary intake of plant sterols stably increases plant sterol levels in the murine brain, J. Lipid Res. 2012 Apr;53(4):726-35.
-
2012Independent validation of the Enhanced Liver Fibrosis (ELF) score in the ANRS HC EP 23 Fibrostar cohort of patients with chronic hepatitis C, Clin. Chem. Lab. Med. 2012 Jan;50(4):693-9.
-
2012Severe transaminitis after interferon-ribavirin therapy in HIV/HCV-coinfected patients: influence of a sustained HCV response, J. Viral Hepat. 2012 Jun;19(6):431-5.
-
2012Discrimination of agonist and antagonist forms of CXCL10 in biological samples, Clin. Exp. Immunol. 2012 Jan;167(1):137-48.
-
2012Posthysterectomy fallopian tube prolapse, J Midlife Health 2012 Jan;3(1):40-1.
-
2012Thymosin alpha-1 with peginterferon alfa-2a/ribavirin for chronic hepatitis C not responsive to IFN/ribavirin: an adjuvant role?, J. Viral Hepat. 2012 Jan;19 Suppl 1:52-9.
-
2012Comparison of eight diagnostic algorithms for liver fibrosis in hepatitis C: new algorithms are more precise and entirely noninvasive, Hepatology 2012 Jan;55(1):58-67.
-
2011Gaining greater insight into HCV emergence in HIV-infected men who have sex with men: the HEPAIG Study, PLoS ONE 2011;6(12):e29322.
-
2011Primary liver cancer is more aggressive in HIV-HCV coinfection than in HCV infection. A prospective study (ANRS CO13 Hepavih and CO12 Cirvir), Clin Res Hepatol Gastroenterol 2012 Jun;36(3):214-21.
-
2011IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes, Hepatology 2012 Feb;55(2):384-94.
-
2011[Individualized treatment of hepatitis C virus infection], Presse Med 2012 Feb;41(2):146-52.
-
2011[New developments in ultrasound imaging for chronic liver diseases: from anatomic imaging to structural and functional imaging], Presse Med 2012 Feb;41(2):153-68.
-
2011Antiviral activity of telaprevir and boceprevir for the treatment of hepatitis C virus infection in treatment-experienced patients, Clin Res Hepatol Gastroenterol 2011 Dec;35 Suppl 2:S59-63.
-
2011A true revolution: enhanced motivation of the patient with rapid loss of virus (or rapid negativation of viral load), relationship between viral and histological cure, Clin Res Hepatol Gastroenterol 2011 Dec;35 Suppl 2:S43-5.
-
2011CX(3)CR1 drives cytotoxic CD4(+)CD28(-) T cells into the brain of multiple sclerosis patients, J. Autoimmun. 2012 Feb;38(1):10-9.
-
2011[New treatments of chronic hepatitis C], Presse Med 2012 Feb;41(2):138-45.
-
2011The role of adherence in virological suppression in patients receiving anti-HBV analogues, Antivir. Ther. (Lond.) 2012;17(2):395-400.
-
2011Targeting angiogenesis in chronic liver diseases with portal hypertension: anti-placenta growth factor inhibitor or multikinase inhibitor sorafenib?, Hepatology 2011 Nov;54(5):1890-1; author reply 1891.
-
2011The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases, Aliment. Pharmacol. Ther. 2011 Nov;34(10):1202-16.
-
2011Impact of hepatitis C triple therapy availability upon the number of patients to be treated and associated costs in France: a model-based analysis, Gut 2012 Feb;61(2):290-6.
-
2011Efficacy of the protease inhibitor BI 201335, polymerase inhibitor BI 207127, and ribavirin in patients with chronic HCV infection, Gastroenterology 2011 Dec;141(6):2047-55; quiz e14.
-
2011[Management of the risk of hepatitis B virus reactivation in patients receiving immunosuppressive and immunomodulatory agents in internal medicine: data from the REACTI-B survey and proposal for a management algorithm], Rev Med Interne 2012 Jan;33(1):4-12.
-
2011Brain endothelial barrier passage by monocytes is controlled by the endothelin system, J. Neurochem. 2012 Jun;121(5):730-7.
-
2011Noninvasive in vivo liver fibrosis evaluation using supersonic shear imaging: a clinical study on 113 hepatitis C virus patients, Ultrasound Med Biol 2011 Sep;37(9):1361-73.
-
2011New treatments for chronic hepatitis C virus infection, Med Mal Infect 2011 Nov;41(11):579-87.
-
2011Chronic liver disease: systemic and splanchnic venous flow mapping with optimized cine phase-contrast MR imaging validated in a phantom model and prospectively evaluated in patients, Radiology 2011 Oct;261(1):144-55.
-
2011Current management and recommendations on hepatitis B therapy in HIV-coinfected patients, Hepatol Int 2013 Jun;7(2):437-42.
-
2011Strategies for bacterial expression of protein-peptide complexes: application to solubilization of papillomavirus E6, Protein Expr. Purif. 2011 Nov;80(1):8-16.
-
2011A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel, Liver Int. 2011 Jul;31 Suppl 2:30-60.
-
2011Applying a system approach to forecast the total hepatitis C virus-infected population size: model validation using US data, Liver Int. 2011 Jul;31 Suppl 2:4-17.
-
2011Telaprevir for retreatment of HCV infection, N. Engl. J. Med. 2011 Jun;364(25):2417-28.
-
2011Telaprevir for previously untreated chronic hepatitis C virus infection, N. Engl. J. Med. 2011 Jun;364(25):2405-16.
-
2011Hepatitis B virus infection and pregnancy, Clin Res Hepatol Gastroenterol 2011 Oct;35(10):618-22.
-
2011Distinct CD4+ CD8+ double-positive T cells in the blood and liver of patients during chronic hepatitis B and C, PLoS ONE 2011;6(5):e20145.
-
2011Pharmacological exposure to ribavirin: a key player in the complex network of factors implicated in virological response and anaemia in hepatitis C treatment, Dig Liver Dis 2011 Nov;43(11):850-5.
-
2011TNF alpha antagonist therapy and safety monitoring, Joint Bone Spine 2011 May;78 Suppl 1:15-185.
-
2011Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial, JAMA 2011 Apr;305(14):1432-40.
-
2011Zirconium nanoparticles prepared by the reduction of zirconium oxide using the RAPET method, Beilstein J Nanotechnol 2011;2:198-203.
-
2011Acute hepatitis A virus infection without IgM antibodies to hepatitis A virus, Ann. Intern. Med. 2011 Apr;154(7):507-8.
-
2011Interferon induced protein 10 remains a useful biomarker of treatment failure in patients stratified for the interleukin-28B rs12979860 haplotype, Hepatology 2011 Apr;53(4):1410-1.
-
2011The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial, Lancet 2011 Mar;377(9771):1096-101, 1101.e1-2.
-
2011Efficacy of hepatitis B sero-vaccination in newborns of African HBsAg positive mothers, Vaccine 2011 Apr;29(16):2846-9.
-
2011Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis, J. Hepatol. 2011 Oct;55(4):756-61.
-
2011Reversible decrease of portal venous flow in cirrhotic patients: a positive side effect of sorafenib, PLoS ONE 2011 Feb;6(2):e16978.
-
2011Viral hepatitis in solid organ transplantation other than liver, J. Hepatol. 2011 Aug;55(2):474-82.
-
2011[Treatment of hepatitis C], Rev Prat 2011 Jan;61(1):55-60.
-
2011[Assessment and reversibility of liver fibrosis in viral hepatitis], Rev Prat 2011 Jan;61(1):39-43.
-
2011[Viral hepatitis: major progress], Rev Prat 2011 Jan;61(1):23-4.
-
2011The impact of human immunodeficiency virus on viral hepatitis, Liver Int. 2011 Jan;31 Suppl 1:135-9.
-
2010Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV, J. Clin. Invest. 2011 Jan;121(1):308-17.
-
2010Adenosine triphosphate-binding cassette transporters mediate chemokine (C-C motif) ligand 2 secretion from reactive astrocytes: relevance to multiple sclerosis pathogenesis, Brain 2011 Feb;134(Pt 2):555-70.
-
2010Association of Parkinson disease-related protein PINK1 with Alzheimer disease and multiple sclerosis brain lesions, Free Radic. Biol. Med. 2011 Feb;50(3):469-76.
-
2010Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infection, J. Hepatol. 2011 Jun;54(6):1114-22.
-
2010Treatment of acute hepatitis C in human immunodeficiency virus-infected patients: the HEPAIG study, Hepatology 2010 Dec;52(6):1915-21.
-
2010High rate of adefovir-lamivudine combination therapy in nucleoside-naïve patients with chronic hepatitis B in France: results of a national survey in 1730 patients, Eur J Gastroenterol Hepatol 2010 Nov;22(11):1290-6.
-
2010Dynamics and fate of USPIO in the central nervous system in experimental autoimmune encephalomyelitis, NMR Biomed 2010 Nov;23(9):1087-96.
-
2010Efficacy and pharmacokinetics of adefovir dipivoxil liquid suspension in patients with chronic hepatitis B and renal impairment, J Clin Pharmacol 2011 Sep;51(9):1293-301.
-
2010Magnetic resonance imaging of monocytes labeled with ultrasmall superparamagnetic particles of iron oxide using magnetoelectroporation in an animal model of multiple sclerosis, Mol Imaging 2010 Oct;9(5):268-77.
-
2010[Treatment of chronic hepatitis B: adherence and safety], Gastroenterol. Clin. Biol. 2010 Sep;34 Suppl 2:S142-8.
-
2010Dry autoclaving for the nanofabrication of sulfides, selenides, borides, phosphides, nitrides, carbides, and oxides, Adv. Mater. Weinheim 2011 Mar;23(10):1179-90.
-
2010Optimization and robustness of blood tests for liver fibrosis and cirrhosis, Clin. Biochem. 2010 Nov;43(16-17):1315-22.
-
2010Management and treatment of chronic hepatitis B virus infection in HIV positive and negative patients: the EPIB 2008 study, J. Hepatol. 2010 Dec;53(6):1006-12.
-
2010Interferon gamma receptor 2 gene variants are associated with liver fibrosis in patients with chronic hepatitis C infection, Gut 2010 Aug;59(8):1120-6.
-
2010Tocilizumab: therapy and safety management, Joint Bone Spine 2010 Jun;77 Suppl 1:S3-100.
-
2010Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial, Lancet 2010 Jul;376(9734):23-32.
-
2010Brief communication: case reports of ribavirin treatment for chronic hepatitis E, Ann. Intern. Med. 2010 Jul;153(2):85-9.
-
2010Care of hepatitis C virus infection in human immunodeficiency virus-infected patients: modifications in three consecutive large surveys between 2004 and 2009, J. Hepatol. 2010 Aug;53(2):230-7.
-
2010HIV-associated obliterative portopathy (HIV-OP) underlies cryptogenic liver disease in HIV-seropositive patients, HIV Med. 2010 Sep;11(8):540-1.
-
2010[Hepatitis B remains a public health problem in France], Arch Pediatr 2010 Mar;17(3 Suppl):1-5.
-
2010Changes to the natural killer cell repertoire after therapeutic hepatitis B DNA vaccination, PLoS ONE 2010 Jan;5(1):e8761.
-
2010The NR1 subunit of NMDA receptor regulates monocyte transmigration through the brain endothelial cell barrier, J. Neurochem. 2010 Apr;113(2):447-53.
-
2010New trends in hepatitis C management, Presse Med 2010 Apr;39(4):446-51.
-
2010Human immunodeficiency virus and hepatitis C infections induce distinct immunologic imprints in peripheral mononuclear cells, Hepatology 2010 Jan;51(1):353.
-
2009Hepatic profile analyses of tipranavir in Phase II and III clinical trials, BMC Infect. Dis. 2009 Dec;9:203.
-
2009Dabigatran versus warfarin in the treatment of acute venous thromboembolism, N. Engl. J. Med. 2009 Dec;361(24):2342-52.
-
2009P-glycoprotein acts as an immunomodulator during neuroinflammation, PLoS ONE 2009 Dec;4(12):e8212.
-
2009T lymphocytes impair P-glycoprotein function during neuroinflammation, J. Autoimmun. 2010 Jun;34(4):416-25.
-
2009Evaluation of high performance liquid chromatography purified leptospiral antigen for the diagnosis of leptospirosis, Jpn. J. Infect. Dis. 2009 Nov;62(6):428-31.
-
2009Automation of the Hepascore and validation as a biochemical index of liver fibrosis in patients with chronic hepatitis C from the ANRS HC EP 23 Fibrostar cohort, Clin. Chim. Acta 2010 Jan;411(1-2):86-91.
-
2009Causes of death in HIV-infected women: persistent role of AIDS. The ‘Mortalité 2000 & 2005’ Surveys (ANRS EN19), Int J Epidemiol 2010 Feb;39(1):135-46.
-
2009Characterization of leptospires using V3 region of 16S rDNA by denaturing gradient gel electrophoresis: a case study, Indian J Med Microbiol 2009 Oct-Dec;27(4):354-7.
-
2009Aspartate aminotransferase to platelet ratio index (APRI) score is inappropriate for assessment of liver fibrosis in HIV-infected patients with hazardous drinking, HIV Med. 2009 Sep;10(8):524; author reply 524-5.
-
2009Response to pegylated interferon alfa-2a and ribavirin in chronic hepatitis C genotype 4, J. Med. Virol. 2009 Sep;81(9):1576-83.
-
2009Human immunodeficiency virus-associated obliterative portopathy underlies unexplained aminotransferase elevations under antiretrovirals, Hepatology 2009 Aug;50(2):660.
-
2009Acquired protein S deficiency leads to obliterative portal venopathy and to compensatory nodular regenerative hyperplasia in HIV-infected patients, AIDS 2009 Jul;23(12):1511-8.
-
2009Treatment of chronic hepatitis C in sickle cell disease and thalassaemic patients with interferon and ribavirin, Eur J Gastroenterol Hepatol 2009 Jul;21(7):726-9.
-
2009Why actively promote vaccination in patients with cirrhosis?, J. Clin. Virol. 2009 Nov;46(3):206-9.
-
2009Treatment of HBV-related cirrhosis, Expert Rev Anti Infect Ther 2009 Jun;7(5):527-35.
-
2009SAFE biopsy: a validated method for large-scale staging of liver fibrosis in chronic hepatitis C, Hepatology 2009 Jun;49(6):1821-7.
-
2009A sequence and structure based method to predict putative substrates, functions and regulatory networks of endo proteases, PLoS ONE 2009 May;4(5):e5700.
-
2009Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men, Gastroenterology 2009 May;136(5):1609-17.
-
2009Telaprevir and peginterferon with or without ribavirin for chronic HCV infection, N. Engl. J. Med. 2009 Apr;360(18):1839-50.
-
2009Dual role of CCR2 in the constitution and the resolution of liver fibrosis in mice, Am. J. Pathol. 2009 May;174(5):1766-75.
-
2009Gamma glutamyl transferase elevation in HIV/Hepatitis C virus-coinfected patients during interferon-ribavirin combination therapy, J. Acquir. Immune Defic. Syndr. 2009 Apr;50(4):429-30.
-
2009Persistently normal alanine aminotransferase levels in HIV/HCV-coinfected patients: the role of steatosis, HIV Med. 2009 Aug;10(7):417-21.
-
2009[ANRS HC 02 RIBAVIC: from multicenter trial to daily practice], Gastroenterol. Clin. Biol. 2009 Mar;33 Suppl 2:S91-3.
-
2009[ANRS HC 02 RIBAVIC: from multicenter trial to daily practice. Conclusions], Gastroenterol. Clin. Biol. 2009 Mar;33 Suppl 2:S118-9.
-
2009[ANRS HC 02 RIBAVIC: impact of steatosis in HIV-HCV co-infection], Gastroenterol. Clin. Biol. 2009 Mar;33 Suppl 2:S110-2.
-
2009[ANRS HC 02 RIBAVIC: histo-pathological impact], Gastroenterol. Clin. Biol. 2009 Mar;33 Suppl 2:S106-9.
-
2009Changes in cancer mortality among HIV-infected patients: the Mortalité 2005 Survey, Clin. Infect. Dis. 2009 Mar;48(5):633-9.
-
2009[Hepatitis B vaccine and demyelinating diseases: debate and disinformation], Presse Med 2009 Apr;38(4):519-23.
-
2009Acute cholestatic hepatitis revealing Mycoplasma pneumoniae infection without lung involvement in an adult patient, Eur J Gastroenterol Hepatol 2009 Feb;21(2):220-1.
-
2009Does early antiretroviral treatment prevent liver fibrosis in HIV/HCV-coinfected patients?, J. Acquir. Immune Defic. Syndr. 2009 Feb;50(2):234-6.
-
2009Insulin resistance impairs sustained virological response rate to pegylated interferon plus ribavirin in HIV-hepatitis C virus-coinfected patients: HOMAVIC-ANRS HC02 Study, Antivir. Ther. (Lond.) 2009;14(6):839-45.
-
2009Effect of antiviral treatment on serum markers of liver fibrosis in HIV-hepatitis C virus-coinfected patients: the Fibrovic 2 Study – ANRS HC02, Antivir. Ther. (Lond.) 2009;14(2):211-9.
-
2009Safety, pharmacokinetics and antiviral effect of BILB 1941, a novel hepatitis C virus RNA polymerase inhibitor, after 5 days oral treatment, Antivir. Ther. (Lond.) 2009;14(1):23-32.
-
2008Symptomatic acute hepatitis C in Egypt: diagnosis, spontaneous viral clearance, and delayed treatment with 12 weeks of pegylated interferon alfa-2a, PLoS ONE 2008;3(12):e4085.
-
2008The accuracy of the FIB-4 index for the diagnosis of mild fibrosis in chronic hepatitis B, Aliment. Pharmacol. Ther. 2009 Feb;29(4):409-15.
-
2008Plasmacytoid dendritic cells move down on the list of suspects: in search of the immune pathogenesis of chronic hepatitis C, J. Hepatol. 2008 Dec;49(6):1069-78.
-
2008A French prospective observational study of the treatment of chronic hepatitis C in drug abusers, Gastroenterol. Clin. Biol. 2008 Oct;32(10):850-7.
-
2008Brief communication: the relationship of regression of cirrhosis to outcome in chronic hepatitis C, Ann. Intern. Med. 2008 Sep;149(6):399-403.
-
2008Adefovir dipivoxil is effective for the treatment of cirrhotic patients with lamivudine failure, Liver Int. 2009 Mar;29(3):420-6.
-
2008Tissue-type plasminogen activator is a regulator of monocyte diapedesis through the brain endothelial barrier, J. Immunol. 2008 Sep;181(5):3567-74.
-
2008Changes in causes of death among adults infected by HIV between 2000 and 2005: The “Mortalité 2000 and 2005” surveys (ANRS EN19 and Mortavic), J. Acquir. Immune Defic. Syndr. 2008 Aug;48(5):590-8.
-
2008Facile synthesis of photoluminescent ZnS and ZnSe nanopowders, Langmuir 2008 Sep;24(18):10462-6.
-
2008A new indication for liver transplantation: nodular regenerative hyperplasia in human immunodeficiency virus-infected patients, Liver Transpl. 2008 Aug;14(8):1194-8.
-
2008Serum alpha-fetoprotein predicts virologic response to hepatitis C treatment in HIV coinfected patients, AIDS 2008 Jul;22(12):1513-5.
-
2008Prevalence and impact of GBV-C, SEN-V and HBV occult infections in HIV-HCV co-infected patients on HCV therapy, J. Hepatol. 2008 Dec;49(6):892-8.
-
2008Expression of defective hepatitis B virus particles derived from singly spliced RNA is related to liver disease, J. Infect. Dis. 2008 Jul;198(2):218-25.
-
2008Influence of liver biopsy on abstinence in alcohol-dependent patients, Alcohol Alcohol. 2008 Sep-Oct;43(5):559-63.
-
2008Risk factors for bacterial infections in HIV/hepatitis C virus-coinfected patients treated with interferon plus ribavirin, AIDS 2008 Jul;22(11):1385-7.
-
2008Management of chronic hepatitis C virus infection in HIV-infected patients, Clin. Infect. Dis. 2008 Jul;47(1):94-101.
-
2008Pathological evolution of hepatitis C virus-“Healthy carriers”, World J. Gastroenterol. 2008 Jun;14(24):3861-5.
-
2008Risk factors for grade 3 or 4 gamma-glutamyl transferase elevation in HIV/hepatitis C virus-coinfected patients, AIDS 2008 Jun;22(10):1234-6.
-
2008Serum alpha-fetoprotein predicts treatment outcome in chronic hepatitis C patients regardless of HCV genotype, PLoS ONE 2008 Jun;3(6):e2391.
-
2008Effects of a 10 T external magnetic field on the thermal decomposition of Fe, Ni, and Co acetyl acetonates, Langmuir 2008 Jul;24(14):7532-7.
-
2008Targeting the tetraspanin CD81 blocks monocyte transmigration and ameliorates EAE, Neurobiol. Dis. 2008 Sep;31(3):413-21.
-
2008Phospholipid signaling during stramenopile development, Plant Signal Behav 2008 Jun;3(6):398-400.
-
2008Prevalence of hepatitis C and hepatitis B infection in the HIV-infected population of France, 2004, Euro Surveill. 2008 May;13(22).
-
2008Erratum to ‘The management of chronic hepatitis B in the immunocompromised patient: recommendations from a single topic meeting’ [J. Clin. Virol. 41 (4) 2008 243-254], J. Clin. Virol. 2008 May;42(1):104-15.
-
2008Protective effects of peroxiredoxin-1 at the injured blood-brain barrier, Free Radic. Biol. Med. 2008 Aug;45(3):256-64.
-
2008Severe weight loss in HIV / HCV-coinfected patients treated with interferon plus ribavirin: incidence and risk factors, J. Viral Hepat. 2008 Apr;15(4):255-60.
-
2008Core-shell nanorods of SnS-C and SnSe-C: synthesis and characterization, Langmuir 2008 May;24(9):5135-9.
-
2008Sexually transmitted hepatitis C virus superinfection in HIV/hepatitis C virus co-infected men who have sex with men, AIDS 2008 Mar;22(5):658-61.
-
2008[HIV and hepatitis C virus coinfection], Gastroenterol. Clin. Biol. 2008 Mar;32(3 Pt 2):S82-9.
-
2008[Alcohol, steatohepatitis, insulin resistance and hepatitis C], Gastroenterol. Clin. Biol. 2008 Mar;32(3 Pt 2):S74-81.
-
2008[Management of chronic hepatitis in 2008], Gastroenterol. Clin. Biol. 2008 Mar;32(3 Pt 2):S71-3.
-
2008[Management of chronic hepatitis C in 2008], Gastroenterol. Clin. Biol. 2008 Mar;32(3 Pt 2):S121-4.
-
2008Response to Schiano et al. Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIV, Am. J. Gastroenterol. 2008 Mar;103(3):808-9.
-
2008Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: analysis of risk factors, Clin. Infect. Dis. 2008 Mar;46(5):768-74.
-
2008Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: the fibrovic study–ANRS HC02, J. Hepatol. 2008 May;48(5):765-73.
-
2008Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement, Brain 2008 Mar;131(Pt 3):800-7.
-
2008The management of chronic hepatitis B in the immunocompromised patient: recommendations from a single topic meeting, J. Clin. Virol. 2008 Apr;41(4):243-54.
-
2008[Chronic hepatitis B: unusual situations: dialysis, renal transplantation and pre-emptive therapy in immune compromised patients], Gastroenterol. Clin. Biol. 2008 Jan;32(1 Pt 2):S34-41.
-
2007MRI of monocyte infiltration in an animal model of neuroinflammation using SPIO-labeled monocytes or free USPIO, J. Cereb. Blood Flow Metab. 2008 Apr;28(4):841-51.
-
2007Effect of sustained virological response on long-term clinical outcome in 113 patients with compensated hepatitis C-related cirrhosis treated by interferon alpha and ribavirin, World J. Gastroenterol. 2007 Nov;13(42):5648-53.
-
2007Treatment of hepatitis C virus in human immunodeficiency virus infected patients in “real life”: modifications in two large surveys between 2004 and 2006, J. Hepatol. 2008 Jan;48(1):35-42.
-
2007[Liver and antiretrovirals: hepatotoxicity, steatosis and monitoring of patients with liver disease], Gastroenterol. Clin. Biol. 2007 Oct;31(10):895-905.
-
2007[A puzzling case of portal hypertension in a patient with human immunodeficiency and hepatitis C virus co-infection], Gastroenterol. Clin. Biol. 2007 Oct;31(10):878-80.
-
2007[The hepatologist and human immunodeficiency virus (HIV): 20 years later…], Gastroenterol. Clin. Biol. 2007 Oct;31(10):875-7.
-
2007Risks factors of liver fibrosis in a cohort of intravenous drug users coinfected with HIV and HCV in the HAART era: the role of mixed steatosis, Gastroenterol. Clin. Biol. 2007 Oct;31(10):822-7.
-
2007Risk factors for anaemia in human immunodeficiency virus/hepatitis C virus-coinfected patients treated with interferon plus ribavirin, J. Viral Hepat. 2007 Sep;14(9):639-44.
-
2007[Management of HCV-HIV patients], Gastroenterol. Clin. Biol. 2007 Aug-Sep;31(8-9 Pt 3):4S7-12.
-
2007High hepatitis C virus viral load in HIV/hepatitis C virus-co-infected patients: a different influence of protease inhibitor and non-protease inhibitor-based HAART?, AIDS 2007 Jul;21(12):1645-8.
-
2007Stable recovery from HCV in HIV-HCV co-infection under antiretroviral therapy, J. Clin. Virol. 2007 Sep;40(1):71-3.
-
2007FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest, Hepatology 2007 Jul;46(1):32-6.
-
2007Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling, FASEB J. 2007 Nov;21(13):3666-76.
-
2007Epidemiology, diagnosis and treatment of chronic hepatitis B in HIV-infected patients (EPIB 2005 STUDY), AIDS 2007 Jun;21(10):1323-31.
-
2007Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel, AIDS 2007 May;21(9):1073-89.
-
2007External magnetic field-induced mesoscopic organization of Fe3O4 pyramids and carbon sheets, Inorg Chem 2007 Jun;46(12):4951-9.
-
2007Impact of hepatitis B virus basic core promoter mutations on T cell response to an immunodominant HBx-derived epitope, Hepatology 2007 May;45(5):1199-209.
-
2007Early virologic failure in HIV-coinfected hepatitis C patients treated with the peginterferon-ribavirin combination: does abacavir play a role?, J. Acquir. Immune Defic. Syndr. 2007 May;45(1):123-5.
-
2007Comparison of SPIO and USPIO for in vitro labeling of human monocytes: MR detection and cell function, Radiology 2007 May;243(2):467-74.
-
2007Rapid and early virological response to chronic hepatitis C treatment with IFN alpha2b or PEG-IFN alpha2b plus ribavirin in HIV/HCV co-infected patients, Gut 2007 Aug;56(8):1111-6.
-
2007[Treatment of hepatitis B. Current strategies], Gastroenterol. Clin. Biol. 2007 Mar;31(3):325-32.
-
2007Liver-related mortality in human-immunodeficiency-virus-infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 Study), J. Viral Hepat. 2007 Mar;14(3):183-8.
-
2007Satisfaction of patients treated for chronic hepatitis C with the peginterferon alfa-2b pen device: the VISA observational study, Gastroenterol. Clin. Biol. 2007 Feb;31(2):180-4.
-
2007Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients, AIDS 2007 Jan;21(2):187-92.
-
2007Serum alpha-foetoprotein level predicts treatment outcome in chronic hepatitis C, Antivir. Ther. (Lond.) 2007;12(5):797-803.
-
2007Reversibility of cirrhosis in HIV/HBV coinfection, Antivir. Ther. (Lond.) 2007;12(2):279-83.
-
2007The constrained amino acid beta-Acc confers potency and selectivity to integrin ligands, Angew. Chem. Int. Ed. Engl. 2007;46(21):3976-8.
-
2006Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection, Hepatology 2006 Dec;44(6):1607-16.
-
2006Diapedesis of monocytes is associated with MMP-mediated occludin disappearance in brain endothelial cells, FASEB J. 2006 Dec;20(14):2550-2.
-
2006Improving anti-HCV therapy, Discov Med 2006 Oct;6(35):187-90.
-
2006Therapeutic vaccination in chronic hepatitis B virus carriers, Expert Rev Vaccines 2006 Oct;5(5):707-16.
-
2006[Impact of resistance to analogue antivirals and therapeutic strategies in situations of dialysis, kidney transplantation, vasculitis, and preemptive treatments in immunosuppressed patients], Gastroenterol. Clin. Biol. 2006 Oct;30(10 Pt 2):3S31-3.
-
2006Treatment of hepatitis C virus and human immunodeficiency virus coinfection: from large trials to real life, J. Viral Hepat. 2006 Oct;13(10):678-82.
-
2006Direct and indirect evidence for the reversibility of cirrhosis, Hum. Pathol. 2006 Dec;37(12):1519-26.
-
2006FIB-4: a simple, inexpensive and accurate marker of fibrosis in HCV-infected patients, Hepatology 2006 Sep;44(3):769; author reply 769-70.
-
2006Improving anti-hepatitis C virus therapy, Expert Opin Biol Ther 2006 Sep;6(9):923-33.
-
2006Mycophenolate sodium-induced hepatotoxicity: first report, Transplantation 2006 Aug;82(4):581.
-
2006Lipoic acid affects cellular migration into the central nervous system and stabilizes blood-brain barrier integrity, J. Immunol. 2006 Aug;177(4):2630-7.
-
2006Hepatitis B virus-human immunodeficiency virus co-infection in France: a cross-sectional multicentre study, Epidemiol. Infect. 2007 Apr;135(3):409-16.
-
2006Synthesis of a conducting SiO2-carbon composite from commercial silicone grease and its conversion to paramagnetic SiO2 particles, J Phys Chem B 2006 Jul;110(27):13420-4.
-
2006[Risk factors for hepatitis C virus transmission to Health Care Workers after occupational exposure: a European case-control study], Rev Epidemiol Sante Publique 2006 Jul;54 Spec No 1:1S23-1S31.
-
2006Thermal decomposition of commercial silicone oil to produce high yield high surface area SiC nanorods, J Phys Chem B 2006 Jun;110(23):11237-40.
-
2006Multicentre study of hepatitis B virus genotypes in France: correlation with liver fibrosis and hepatitis B e antigen status, J. Viral Hepat. 2006 May;13(5):329-35.
-
2006Structural properties of orexins for activation of their receptors, J. Pept. Sci. 2006 Apr;12(4):258-66.
-
2006Hepatic steatosis in HIV-HCV coinfected patients: analysis of risk factors, AIDS 2006 Feb;20(4):525-31.
-
2006[Natural history of hepatitis B infection], Presse Med 2006 Feb;35(2 Pt 2):308-16.
-
2006Comparison of serum hepatitis C virus (HCV) RNA and core antigen levels in patients coinfected with human immunodeficiency virus and HCV and treated with interferon plus ribavirin, J. Clin. Microbiol. 2006 Feb;44(2):417-22.
-
2006Identification of the key residue of calcitonin gene related peptide (CGRP) 27-37 to obtain antagonists with picomolar affinity at the CGRP receptor, J. Med. Chem. 2006 Jan;49(2):616-24.
-
2006Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d’Etude des Lymphomes de l’Adulte programs, J. Clin. Oncol. 2006 Feb;24(6):953-60.
-
2006Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy, AIDS 2006 Jan;20(2):233-40.
-
2006Optimizing treatment outcomes in chronic hepatitis C: management of non-response, Antivir. Ther. (Lond.) 2006;11(8):955-70.
-
2005Synthesis of WO3 nanorods by reacting WO(OMe)4 under autogenic pressure at elevated temperature followed by annealing, Inorg Chem 2005 Dec;44(26):9938-45.
-
2005Diagnostic accuracy of the fibrotest in hemodialysis and renal transplant patients with chronic hepatitis C virus, Transplantation 2005 Dec;80(11):1550-5.
-
2005Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection, J. Hepatol. 2006;44(1 Suppl):S28-34.
-
2005Spontaneous hepatic decompensation in patients coinfected with HIV and hepatitis C virus during interferon-ribavirin combination treatment, Clin. Infect. Dis. 2005 Dec;41(12):1806-9.
-
2005Hepatitis C virus in the semen of men coinfected with HIV-1: prevalence and origin, AIDS 2005 Nov;19(16):1827-35.
-
2005Efficacy and safety of adefovir dipivoxil in kidney recipients, hemodialysis patients, and patients with renal insufficiency, Transplantation 2005 Oct;80(8):1086-92.
-
2005Risk factors for hepatitis C virus transmission to health care workers after occupational exposure: a European case-control study, Clin. Infect. Dis. 2005 Nov;41(10):1423-30.
-
2005[The irreversibility of cirrhosis: “the jostle dogma”], Rev Prat 2005 Sep;55(14):1549-51.
-
2005The core-specific precursor T cell response is directed to the N-terminal and central parts of the protein and positively correlates to the viral load in chronically HCV-infected patients, Virology 2005 Sep;340(2):318-25.
-
2005The significance of anemia in squamous cell head and neck cancer treated with surgery and postoperative radiotherapy, Oral Oncol. 2006 Feb;42(2):131-8.
-
2005Risk factors for symptomatic mitochondrial toxicity in HIV/hepatitis C virus-coinfected patients during interferon plus ribavirin-based therapy, J. Acquir. Immune Defic. Syndr. 2005 Sep;40(1):47-52.
-
2005Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers, Vaccine 2006 May;24(21):4482-9.
-
2005Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study, J. Viral Hepat. 2005 Jul;12(4):405-13.
-
2005Hepatitis B virus genotypes and extrahepatic manifestations, J. Hepatol. 2005 Nov;43(5):764-70.
-
2005Fabrication and magnetic properties of Ni nanospheres encapsulated in a fullerene-like carbon, J Phys Chem B 2005 May;109(19):9495-8.
-
2005Acute hepatitis C infection in HIV positive men who have sex with men in Paris, France, 2001-2004, Euro Surveill. 2005 May;10(5):115-7.
-
2005Concurrent outbreak of leptospirosis and dengue in Mumbai, India, 2002, J. Trop. Pediatr. 2005 Jun;51(3):174-81.
-
2005Applied magnetic field rejects the coating of ferromagnetic carbon from the surface of ferromagnetic cobalt: RAPET of CoZr2(acac)2(OiPr)8, J Phys Chem B 2005 Apr;109(13):6121-5.
-
2005[Treatment of delta (type D) hepatitis], Gastroenterol. Clin. Biol. 2005 Apr;29(4):384-7.
-
2005[Epidemiology and natural history of hepatitis B], Rev Prat 2005 Mar;55(6):599-606.
-
2005Impaired expression of the peroxisome proliferator-activated receptor alpha during hepatitis C virus infection, Gastroenterology 2005 Feb;128(2):334-42.
-
2005[Human immunodeficiency virus (HIV) and hepatitis C virus (HCV) coinfection: epidemiology, severity and recent therapeutic strategies], Rev Med Interne 2005 Apr;26(4):267-70.
-
2005The impact of haematopoietic growth factors on the management and efficacy of antiviral treatment in patients with hepatitis C virus, Antivir. Ther. (Lond.) 2005;10(6):769-76.
-
2005Leptospiral pneumonia, Indian J Pediatr 2005 Jan;72(1):86.
-
2004Prevalence of mixed cryoglobulins in relation to CD4 cell count among patients coinfected with HIV and hepatitis C virus, Clin. Infect. Dis. 2005 Jan;40(2):306-8.
-
2004Flavonoids influence monocytic GTPase activity and are protective in experimental allergic encephalitis, J. Exp. Med. 2004 Dec;200(12):1667-72.
-
2004Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial, JAMA 2004 Dec;292(23):2839-48.
-
2004[Should HCV patients co-infected with HIV be treated? When? How?], Med Mal Infect 2004 Nov;34 Spec No 2:22-4.
-
2004Histological response in patients treated by interferon plus ribavirin for hepatitis C virus-related severe fibrosis, Eur J Gastroenterol Hepatol 2004 Nov;16(11):1219-27.
-
2004Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers, Hepatology 2004 Oct;40(4):874-82.
-
2004Antigenic relevance of F protein in chronic hepatitis C virus infection, Hepatology 2004 Oct;40(4):900-9.
-
2004Histopathologic efficacy of ribavirin monotherapy in kidney allograft recipients with chronic hepatitis C, Transplantation 2004 Sep;78(6):853-7.
-
2004Reactions under autogenic pressure at elevated temperature (RAPET) of various alkoxides: formation of metals/metal oxides-carbon core-shell structures, Chemistry 2004 Sep;10(18):4467-73.
-
2004Hepatitis viruses and human immunodeficiency virus co-infection: pathogenesis and treatment, J. Hepatol. 2004 Jul;41(1):156-66.
-
2004The Effect of a Magnetic Field on a RAPET (Reaction under Autogenic Pressure at Elevated Temperature) of MoO(OMe)(4): Fabrication of MoO(2) Nanoparticles Coated with Carbon or Separated MoO(2) and Carbon Particles, J Phys Chem B 2004 May;108(20):6322-7.
-
2004[The role of contrast-enhanced ultrasonography for the detection of hepatocellular carcinoma], J Radiol 2004 May;85(5 Pt 2):690-703.
-
2004Intrahepatic hepatitis C virus RNA quantification in microdissected hepatocytes, J. Hepatol. 2004 Apr;40(4):682-8.
-
2004Impact of cytomorphological detection of circulating tumor cells in patients with liver cancer, Hepatology 2004 Mar;39(3):792-7.
-
2004Influence of HFE gene polymorphism on the progression and treatment of chronic hepatitis C, J. Viral Hepat. 2004 Mar;11(2):175-82.
-
2004HIV infection and hepatic enzyme abnormalities: intricacies of the pathogenic mechanisms, Clin. Infect. Dis. 2004 Mar;38 Suppl 2:S65-72.
-
2004Surprisingly stable helical conformations in alpha/beta-peptides by incorporation of cis-beta-aminocyclopropane carboxylic acids, Angew. Chem. Int. Ed. Engl. 2004 Jan;43(4):511-4.
-
2004Neonatal outbreak of Salmonella worthington in a general hospital, Indian J Med Microbiol 2004 Jan-Mar;22(1):51-3.
-
2004Reversibility of hepatitis C virus-related cirrhosis, Hum. Pathol. 2004 Jan;35(1):107-12.
-
2004Evolution of hepatitis B viral load and viral genome sequence during adefovir dipivoxil therapy, J. Viral Hepat. 2004 Jan;11(1):74-83.
-
2003Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: a quantitative MRI study, Brain 2004 Mar;127(Pt 3):616-27.
-
2003[Nucleoside analogues resistance in the treatment of chronic hepatitis B virus infection], Rev Med Interne 2003 Dec;24(12):786-93.
-
2003RhoA activation promotes transendothelial migration of monocytes via ROCK, J. Leukoc. Biol. 2004 Mar;75(3):523-8.
-
2003Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study), AIDS 2003 Aug;17(12):1803-9.
-
2003Veno-occlusive disease of the liver in renal transplant patients, Nephrol. Dial. Transplant. 2003 Aug;18(8):1663-6.
-
2003Heparan sulfate proteoglycans modulate monocyte migration across cerebral endothelium, J. Neuropathol. Exp. Neurol. 2003 Jul;62(7):780-90.
-
2003[Liver and ageing: clinical aspects], Gastroenterol. Clin. Biol. 2003 May;27(5):540-7.
-
2003Retreatment with interferon and ribavirin vs interferon alone according to viraemia in interferon responder-relapser hepatitis C patients: a prospective multicentre randomized controlled study, J. Viral Hepat. 2003 May;10(3):215-23.
-
2003Reinforced interferon alpha-2b and ribavirin is more effective than standard combination therapy in the retreatment of chronic hepatitis C previously nonresponsive to interferon: a randomized trial, J. Viral Hepat. 2003 May;10(3):197-204.
-
2003Flavonoids inhibit myelin phagocytosis by macrophages; a structure-activity relationship study, Biochem. Pharmacol. 2003 Mar;65(5):877-85.
-
2003The expression of hepatitis B spliced protein (HBSP) encoded by a spliced hepatitis B virus RNA is associated with viral replication and liver fibrosis, J. Hepatol. 2003 Mar;38(3):343-8.
-
2003Immunomodulatory drugs and therapeutic vaccine in chronic hepatitis B infection, J. Hepatol. 2003;39 Suppl 1:S151-9.
-
2003[Late presentation of Wilson’s disease as cirrhosis complicating hepatocellular carcinoma], Gastroenterol. Clin. Biol. 2003 Jan;27(1):130-1.
-
2003[New recommendations for diagnosis and virological monitoring of viral hepatitis], Gastroenterol. Clin. Biol. 2003 Jan;27(1):89.
-
2002An urban outbreak of leptospirosis in Mumbai, India, Jpn. J. Infect. Dis. 2002 Dec;55(6):194-6.
-
2002[Hepatitis B virus genotypes: clinical, epidemiological and therapeutic implications], Gastroenterol. Clin. Biol. 2002 Nov;26(11):1005-12.
-
2002[Atheroma and hepatitis C virus], Gastroenterol. Clin. Biol. 2002 Nov;26(11):989-90.
-
2002Controversies about the histological features of chronic HCV patients with persistently normal alanine transaminase levels: what can be done about the present definition?, Gastroenterology 2002 Nov;123(5):1748-9; author reply 1749.
-
2002N-acetylcysteine for paracetamol poisoning: effect on prothrombin, Lancet 2002 Oct;360(9340):1115.
-
2002Histological features and HLA class II alleles in hepatitis C virus chronically infected patients with persistently normal alanine aminotransferase levels, Gut 2002 Oct;51(4):585-90.
-
2002[Viral hepatitis. Biological hepatic anomalies in an asymptomatic patient], Rev Prat 2002 Sep;52(14):1605-17.
-
2002Transmission of group II heteronymous pathways is enhanced in rigid lower limb of de novo patients with Parkinson’s disease, Brain 2002 Sep;125(Pt 9):2125-33.
-
2002NNRTI-related or -unrelated hepatotoxicity?, Hepatology 2002 Aug;36(2):512-3; author reply 513-4.
-
2002HCV infection and hemodialysis, Semin. Nephrol. 2002 Jul;22(4):331-9.
-
2002Characterization of low- and very-low-density hepatitis C virus RNA-containing particles, J. Virol. 2002 Jul;76(14):6919-28.
-
2002Interferon-beta directly influences monocyte infiltration into the central nervous system, J. Neuroimmunol. 2002 Jun;127(1-2):69-79.
-
2002Signal-regulatory protein alpha-CD47 interactions are required for the transmigration of monocytes across cerebral endothelium, J. Immunol. 2002 Jun;168(11):5832-9.
-
2002Human leukocyte antigen class II alleles may contribute to the severity of hepatitis C virus-related liver disease, J. Infect. Dis. 2002 Jul;186(1):106-9.
-
2002[Co-infection HIV/HBV], Gastroenterol. Clin. Biol. 2002 May;26(5):518-21.
-
2002[Treatment of chronic hepatitis C in patients with HIV coinfection: efficacy and tolerance], Gastroenterol. Clin. Biol. 2002 Apr;26 Spec No 2:B264-73.
-
2002Hepatitis C and human immune deficiency coinfection at the era of highly active antiretroviral therapy, J. Viral Hepat. 2002 Jan;9(1):1-8.
-
2002Severe evolution of chronic hepatitis C in renal transplantation: a case control study, Nephrol. Dial. Transplant. 2002 Jan;17(1):129-33.
-
2001[Hepavir, the first observational study of one cohort of patients treated with alpha-2a interferon, monotherapy. Evaluation of asthenia and its social consequences], Gastroenterol. Clin. Biol. 2001 Dec;25(12):1061-6.
-
2001Hepatitis activity index is a key factor in determining the natural history of chronic hepatitis C, Hum. Pathol. 2001 Sep;32(9):904-9.
-
2001Impact of medical recommendations on alcohol consumption in HCV positive patients, J. Hepatol. 2001 Aug;35(2):312-3.
-
2001Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely “occult”?, Hepatology 2001 Jul;34(1):194-203.
-
2001Efficacy and limitations of a specific immunotherapy in chronic hepatitis B, J. Hepatol. 2001 Jun;34(6):917-21.
-
2001Side effects of interferon-alpha in treating hepatitis C virus infection, Transplant. Proc. 2001 May;33(3):2327-9.
-
2001The tolerance and efficacy of interferon-alpha in haemodialysis patients with HCV infection: a multicentre, prospective study, Nephrol. Dial. Transplant. 2001 May;16(5):1017-23.
-
2001[Management of C virus infection in patients coinfected with HIV treated with antiretroviral agents], Presse Med 2001 Apr;30(14):677-82.
-
2001[Hepatitis C virus and human immunodeficiency virus co-infection], Gastroenterol. Clin. Biol. 2001 Apr;25(4 Suppl):B152-6.
-
2001Immunotherapy of chronic hepatitis B by anti HBV vaccine: from present to future, Vaccine 2001 Mar;19(17-19):2395-9.
-
2001[Treatments for hepatitis virus C infections], Gastroenterol. Clin. Biol. 2001 Mar;25(3):287-307.
-
2001Vaccination of chronic hepatitis B virus carriers with preS2/S envelope protein is not associated with the emergence of envelope escape mutants, J. Gen. Virol. 2001 Feb;82(Pt 2):367-71.
-
2001[Prevention and treatment of viral hepatitis in renal insufficiency conditions], Nephrologie 2001;22(7):339-47.
-
2001[HVB and HVC infections in nephrology], Nephrologie 2001;22(6):321-2.
-
2000Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early report, Gut 2000 Nov;47(5):694-7.
-
2000Effect of pregnancy on chronic hepatitis C: a case-control study, Lancet 2000 Oct;356(9238):1328-9.
-
2000Is there a relationship between hepatitis C virus infection and antiretroviral-associated lipoatrophy?, AIDS 2000 Sep;14(13):2055.
-
2000Dilated bile duct in patients receiving narcotic substitution: an early report, J. Clin. Gastroenterol. 2000 Sep;31(2):159-61.
-
2000Impact of TT virus infection in acute and chronic, viral- and non viral-related liver diseases, J. Hepatol. 2000 Jul;33(1):121-7.
-
2000Recovery from chronic hepatitis C in long-term responders to ribavirin plus interferon alfa, Lancet 2000 Jul;356(9223):41.
-
2000Combination of ribavirin and interferon-alfa surpasses high doses of interferon-alfa alone in patients with genotype-1b-related chronic hepatitis C, Hepatology 2000 Jun;31(6):1338-44.
-
2000HBV genotypic resistance to lamivudine in kidney recipients and hemodialyzed patients, Transplantation 2000 May;69(10):2090-4.
-
2000[Clinical forms and prognosis of hepatitis C], Rev Prat 2000 May;50(10):1083-8.
-
2000Abnormal reciprocal inhibition between antagonist muscles in Parkinson’s disease, Brain 2000 May;123 ( Pt 5):1017-26.
-
2000Immune therapy of hepatitis B virus (HBV) chronic infection. European experience, Acta Gastroenterol. Belg. 2000 Apr-Jun;63(2):194-6.
-
2000[Treatment of viral hepatitis in drug addicts], Ann Med Interne (Paris) 2000 Apr;151 Suppl A:A33-9.
-
2000Hepatitis and solid organ transplantation, Transplant. Proc. 2000 Mar;32(2):454-7.
-
2000Immune therapy of hepatitis B virus chronic infection, Hepatology 2000 Feb;31(2):548-9.
-
2000Treatment of hepatitis C virus infection in dialysis patients, Nephrol. Dial. Transplant. 2000;15 Suppl 8:46-8.
-
1999Hepatitis B virus genotypic resistance to lamivudine, Ann. Intern. Med. 1999 Nov;131(9):716-7.
-
1999What are the risks involved in kidney transplantation that is probably hepatitis B related, Pediatr. Nephrol. 1999 Oct;13(8):720.
-
1999[Coinfection of hepatitis C virus and human immunodeficiency virus and antiretroviral multitherapies], Gastroenterol. Clin. Biol. 1999 Aug-Sep;23(8-9):878-81.
-
1999A randomized trial of ribavirin and interferon-alpha vs. interferon-alpha alone in patients with chronic hepatitis C who were non-responders to a previous treatment. Multicenter Study Group under the coordination of the Necker Hospital, Paris, France, J. Hepatol. 1999 Jul;31(1):1-7.
-
1999Significance of repeatedly normal aminotransferase activities in HCV-infected patients, J. Clin. Gastroenterol. 1999 Jul;29(1):71-5.
-
1999Epidemiological and virological analysis of couples infected with hepatitis C virus, Gut 1999 Jul;45(1):112-6.
-
1999Specific vaccine therapy in chronic hepatitis B: induction of T cell proliferative responses specific for envelope antigens, J. Infect. Dis. 1999 Jul;180(1):15-26.
-
1999Lack of association between HCV infection and HIV-related lymphoma, Br. J. Haematol. 1999 May;105(2):568-9.
-
1999[Treatment of chronic hepatitis C: interferon alpha-2b alone or in combination with ribavirin], Gastroenterol. Clin. Biol. 1999 Apr;23(4):541-4.
-
1999[Prophylactic vaccination against hepatitis B: present and future], Gastroenterol. Clin. Biol. 1999 Apr;23(4):452-63.
-
1999Handedness-related asymmetry in transmission in a system of human cervical premotoneurones, Exp Brain Res 1999 Apr;125(3):323-34.
-
1999Triggering of acute alcoholic hepatitis by alpha-interferon therapy, J. Hepatol. 1999 Apr;30(4):722-5.
-
1999Liver resection and needle liver biopsy cause hematogenous dissemination of liver cells, Hepatology 1999 Mar;29(3):879-82.
-
1999Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity, J. Hepatol. 1999 Feb;30(2):185-91.
-
1999Treatment of chronic hepatitis C in special groups, J. Hepatol. 1999;31 Suppl 1:205-9.
-
1999Treatment of chronic hepatitis C, Acta Gastroenterol. Belg. 1999 Jan-Mar;62(1):32-9; discussion 39-40.
-
1998[Interactions between the human immunodeficiency virus and hepatitis C virus], Rev Med Interne 1998 Dec;19(12):885-91.
-
1998Hepatitis C virus (HCV) hypervariable region 1 complexity does not correlate with severity of liver disease, HCV type, viral load or duration of infection, J. Hepatol. 1998 Nov;29(5):689-94.
-
1998Rapidly evolving hepatitis C virus-related cirrhosis in a human immunodeficiency virus-infected patient receiving triple antiretroviral therapy, Clin. Infect. Dis. 1998 Nov;27(5):1255-8.
-
1998Impact of co-infection by hepatitis B virus and hepatitis C virus in renal transplantation, Transplant. Proc. 1998 Sep;30(6):2820-2.
-
1998Predictive factors for development of cirrhosis in parenterally acquired chronic hepatitis C: a comparison between immunocompetent and immunocompromised patients, J. Hepatol. 1998 Jul;29(1):12-9.
-
1998Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users, J. Hepatol. 1998 Jun;28(6):945-50.
-
1998ESBRA 1997 Award lecture: relationship between excessive alcohol drinking and viral infections, Alcohol Alcohol. 1998 May-Jun;33(3):202-6.
-
1998Tritherapy for human immunodeficiency virus infection does not modify replication of hepatitis C virus in coinfected subjects, Clin. Infect. Dis. 1998 May;26(5):1104-6.
-
1998Immunotherapy of chronic hepatitis B by anti HBV vaccine, Acta Gastroenterol. Belg. 1998 Apr-Jun;61(2):228-33.
-
1998Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients, Transplantation 1998 Mar;65(5):667-70.
-
1998[Clinical and Biological Gastroenterology: evaluation of Hepatology division, 1995 to 1997], Gastroenterol. Clin. Biol. 1998 Mar;22(3):299-300.
-
1998Hepatitis G virus infection in hepatitis C virus-positive patients co-infected or not with hepatitis B virus and/or human immunodeficiency virus, J. Viral Hepat. 1998 Mar;5(2):123-30.
-
1998Overactivity of cervical premotor neurons in Parkinson’s disease, J. Neurol. Neurosurg. Psychiatr. 1998 Feb;64(2):166-71.
-
1998Characteristics and treatment of hepatitis C virus infection in HIV-coinfected subjects, AIDS Patient Care STDS 1998 Jan;12(1):11-9.
-
1998[Murderous impulses in two patients with chronic hepatitis C treated with interferon alpha], Gastroenterol. Clin. Biol. 1998 Jan;22(1):105-6.
-
1997Spontaneous and iatrogenic spreading of liver-derived cells into peripheral blood of patients with primary liver cancer, Hepatology 1997 Oct;26(4):998-1005.
-
1997Mutations in the nonstructural 5A region of hepatitis C virus and response of chronic hepatitis C to interferon alfa, Gastroenterology 1997 Aug;113(2):567-72.
-
1997Hepatitis C virus genome complexity correlates with response to interferon therapy: a study in French patients with chronic hepatitis C, Hepatology 1997 May;25(5):1250-4.
-
1997Hepatitis C virus-related fibrosing cholestatic hepatitis after renal transplantation, Transplantation 1997 Jan;63(1):158-60.
-
1997[Clinical significance of detection and quantification of hepatitis C virus RNA in hemodialysis: proposal for a rational diagnostic strategy], Nephrologie 1997;18(2):53-8.
-
1997Hepatitis C virus genotypes in French haemophiliacs: kinetics and reappraisal of mixed infections, J. Med. Virol. 1997 Jan;51(1):36-41.
-
1996Reciprocal interactions between human immunodeficiency virus and hepatitis C virus infections, Clin. Infect. Dis. 1996 Nov;23(5):1117-25.
-
1996Improvement of the CD4 cell count after alcohol withdrawal in HIV-positive alcoholic patients, AIDS 1996 Sep;10(11):1293-4.
-
1996Long-term outcome of hepatitis C infection after liver transplantation, N. Engl. J. Med. 1996 Aug;335(7):522; author reply 522-3.
-
1996The long-term virologic and pathologic impact of renal transplantation on chronic hepatitis B virus infection, Transplantation 1996 Jul;62(2):297-9.
-
1996Azathioprine hepatitis in kidney transplant recipients. A predisposing role of chronic viral hepatitis, Transplantation 1996 Jun;61(12):1774-6.
-
1996[Treatment of chronic viral hepatitis], Ann Gastroenterol Hepatol (Paris) 1996 Mar-Apr;32(2):85-7.
-
1996Alpha-interferon for chronic active hepatitis B in human immunodeficiency virus-infected patients, Gastroenterol. Clin. Biol. 1996;20(11):968-71.
-
1996[Hepatotropic virus and renal transplantation], Gastroenterol. Clin. Biol. 1996;20(12):1058-65.
-
1996[Economics and health policy: the example of hepatitis C viruses], Gastroenterol. Clin. Biol. 1996;20(12):1049-52.
-
1996[Should healthy carriers of HBs antigen be followed-up?], Gastroenterol. Clin. Biol. 1996;20(10):727-9.
-
1996Effectiveness and tolerance of interferon-alpha 2b in the treatment of chronic hepatitis C in haemodialysis patients, Nephrol. Dial. Transplant. 1996;11 Suppl 4:58-61.
-
1996[Primary non-Hodgkin’s lymphomas of the liver in human immunodeficiency virus infected patients. Three cases], Gastroenterol. Clin. Biol. 1996;20(3):307-11.
-
1996[Liver, biliary tracts and human immunodeficiency virus infection. 2: hepatobiliary complications of AIDS], Gastroenterol. Clin. Biol. 1996;20(3):281-93.
-
1996[Liver, biliary tracts and human immunodeficiency virus infection. 1:q liver, HIV and hepatitis B, C and D viruses], Gastroenterol. Clin. Biol. 1996;20(3):269-80.
-
1995[In situ hybridization for the detection of hepatitis C virus RNA in mononuclear cells of peripheral blood from infected patients], Orv Hetil 1995 Oct;136(42):2267-71.
-
1995Serum hepatitis C virus (HCV) RNA: a reliable tool for evaluating HCV-related liver disease in anti-HCV-positive blood donors with persistently normal alanine aminotransferase values, Transfusion 1995 Sep;35(9):750-3.
-
1995In vivo and in vitro expression of defective hepatitis B virus particles generated by spliced hepatitis B virus RNA, Hepatology 1995 Jul;22(1):10-9.
-
1995Efficacy and tolerance of alpha-2b interferon therapy on HCV infection of hemodialyzed patients, Kidney Int. 1995 May;47(5):1412-8.
-
1995Hepatocellular carcinoma in alcoholics, Alcohol 1995 Mar-Apr;12(2):117-20.
-
1995Value of liver biopsy for the rapid diagnosis of infection in human immunodeficiency virus-infected patients who have unexplained fever and elevated serum levels of alkaline phosphatase or gamma-glutamyl transferase, Clin. Infect. Dis. 1995 Mar;20(3):606-10.
-
1995The changing relative prevalence of hepatitis C virus genotypes: evidence in hemodialyzed patients and kidney recipients, Gastroenterology 1995 Feb;108(2):581-3.
-
1995Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group, Ann. Intern. Med. 1995 Feb;122(3):161-8.
-
1995Evidence of non-A, non-B, non-C infection in chronic hepatitis by polymerase chain reaction testing for hepatitis B and C viruses, J. Hepatol. 1995 Feb;22(2):125-9.
-
1995Immunotherapy of chronic hepatitis B by anti HBV vaccine, Biomed. Pharmacother. 1995;49(3):105-9.
-
1995Hepatitis C virus infection in hemodialyzed patients and kidney allograft recipients, Adv. Nephrol. Necker Hosp. 1995;24:315-30.
-
1995Clinical impact of drug addiction in alcoholics, Alcohol Alcohol. 1995 Jan;30(1):55-60.
-
1995Vaccination against hepatitis A virus in French hemophilic children, Vox Sang. 1995;69(1):80-1.
-
1994Effects of interleukin-2 on hepatitis B vaccination in uraemic patients, Lancet 1994 Nov;344(8933):1369.
-
1994Low-dose recombinant leukocyte interferon-alpha treatment of hepatitis C viral infection in renal transplant recipients. A pilot study, Transplantation 1994 Sep;58(5):625-8.
-
1994Absence of association between HLA antigens and chronicity of viral hepatitis in haemodialyzed patients, J. Hepatol. 1994 Sep;21(3):388-93.
-
1994Impact and evolution of peliosis hepatis in renal transplant recipients, Transplantation 1994 Aug;58(3):315-6.
-
1994Eradication of hepatitis C virus RNA after alpha-interferon therapy, Ann. Intern. Med. 1994 Aug;121(4):276-7.
-
1994Specific vaccine therapy in chronic hepatitis B infection, Lancet 1994 Jul;344(8918):342.
-
1994PGA score in diagnosis of alcoholic fibrosis, Lancet 1994 Mar;343(8900):803.
-
1994Influence of human immunodeficiency virus infection on hepatitis delta virus superinfection in chronic HBsAg carriers, J. Viral Hepat. 1994;1(2):131-7.
-
1994Detection of hepatitis C virus RNA in peripheral blood mononuclear cells of infected patients by in situ hybridization, Blood 1994 Jan;83(1):269-73.
-
1994[Viral hepatitis in hemodialysis and renal transplantation patients], Nephrologie 1994;15(3):191-5.
-
1994Effectiveness of adenine arabinoside 5′-monophosphate in kidney transplant recipients with chronic active hepatitis B, Nephrol. Dial. Transplant. 1994;9(7):820-3.
-
1993Lack of evidence for a role of HCV in hepatitis-associated aplastic anaemia, Br. J. Haematol. 1993 Dec;85(4):808-10.
-
1993Hepatitis C virus RNA in anti-HCV positive hemodialyzed patients: significance and therapeutic implications, Kidney Int. 1993 Nov;44(5):1097-100.
-
1993[Efficacy of immunotherapy with vaccination against hepatitis B virus on virus B multiplication], C. R. Acad. Sci. III, Sci. Vie 1993 Jul;316(7):688-91.
-
1993HCV infection in alcoholics, Gastroenterol. Jpn. 1993 May;28 Suppl 5:88-90.
-
1993Secondary immune response to hepatitis B virus vaccine in alcoholics, Alcohol. Clin. Exp. Res. 1993 Apr;17(2):295-8.
-
1993Efficacy of adenine arabinoside 5′-monophosphate in kidney recipients with chronic active hepatitis B: a pilot study, Transplant. Proc. 1993 Feb;25(1 Pt 2):1446-9.
-
1993Microsporidia infection in patients with the human immunodeficiency virus and unexplained cholangitis, N. Engl. J. Med. 1993 Jan;328(2):95-9.
-
1992Absence of hepatitis delta virus infection in chronic hemodialysis and kidney transplant patients in france, Transplantation 1992 Dec;54(6):1096-7.
-
1992Herpesvirus infection of the respiratory tract in patients with alcoholic hepatitis, Alcohol. Clin. Exp. Res. 1992 Oct;16(5):979-81.
-
1992Serum hepatitis C virus RNA and hepatitis B virus DNA in non-A, non-B post-transfusional and sporadic chronic hepatitis, J. Hepatol. 1992 Sep;16(1-2):184-9.
-
1992Enterocytozoon bieneusi infection in acquired immunodeficiency syndrome-related sclerosing cholangitis, Gastroenterology 1992 May;102(5):1778-81.
-
1992Hepatitis C virus in kidney recipients. Epidemiology and impact on renal transplantation, J. Hepatol. 1992 May;15(1-2):202-6.
-
1992Interactions between human immunodeficiency virus-1, hepatitis delta virus and hepatitis B virus infections in 260 chronic carriers of hepatitis B virus, Hepatology 1992 Apr;15(4):578-83.
-
1992Hepatitis C viremia and anti-HCV antibodies in alcoholics, J. Hepatol. 1992 Mar;14(2-3):381-4.
-
1991[Hepatitis C in kidney recipients. Epidemiology and impact on kidney transplantation], Presse Med 1991 Nov;20(40):2025-7.
-
1991[Mechanism of action of adenosine on intracellular calcium and platelet aggregation], Kardiologiia 1991 Nov;31(11):76-9.
-
1991Hepatic activity and mRNA expression of aspartate aminotransferase isoenzymes in alcoholic and nonalcoholic liver disease, Hepatology 1991 Oct;14(4 Pt 1):620-5.
-
1991Dexamethasone for alcohol withdrawal, Ann. Intern. Med. 1991 Apr;114(8):705-6.
-
1991Association between HCV and HBV infection in hepatocellular carcinoma and alcoholic liver disease, J. Hepatol. 1991 Jan;12(1):70-4.
-
1991An overview of serum mitochondrial aspartate aminotransferase (mAST) activity as a marker of chronic alcohol abuse, Alcohol Alcohol Suppl 1991;1:455-7.
-
1991Hepatitis C infection in alcoholics, Alcohol Alcohol Suppl 1991;1:321-2.
-
1990Genetic basis of nonresponse to hepatitis B vaccine in hemodialyzed patients, J. Hepatol. 1990 Nov;11(3):385-7.
-
1990Is hepatitis C virus involved in hepatitis-associated aplastic anemia?, Ann. Intern. Med. 1990 Sep;113(6):435-7.
-
1990Properties of human liver cytosolic aspartate aminotransferase mRNAs generated by alternative polyadenylation site selection, Biochemistry 1990 Jun;29(22):5293-9.
-
1990Chronic hepatitis in kidney allograft recipients, Lancet 1990 Apr;335(8694):878-80.
-
1990Diagnostic value of serum gamma-glutamyl-transferase activity and mean corpuscular volume in alcoholic patients with or without cirrhosis, Alcohol. Clin. Exp. Res. 1990 Apr;14(2):250-4.
-
1990[Malignant histiocytosis. Remission for more than 5 years], Presse Med 1990 Feb;19(5):218.
-
1989Regulation of cytosolic aspartate aminotransferase mRNAs in the Fao rat hepatoma cell line by dexamethasone, insulin and cyclic AMP, Eur. J. Biochem. 1989 Dec;186(1-2):79-85.
-
1989Chromosomal localization of human aspartate aminotransferase genes by in situ hybridization, Hum. Genet. 1989 Sep;83(2):159-64.
-
1989Hepatitis delta virus infection in French male HBsAg-positive homosexuals, Hepatology 1989 Sep;10(3):342-5.
-
1989An epidemiological and clinical study of transaminase levels and hepatitis B antibodies in 1,100 blood donors, Vox Sang. 1989;57(1):43-8.
-
1988Nucleotide sequence and tissue distribution of the human mitochondrial aspartate aminotransferase mRNA, Biochem. Biophys. Res. Commun. 1988 Dec;157(3):1309-15.
-
1988Liver diseases and hepatic complications in renal transplant patients, Adv. Nephrol. Necker Hosp. 1988;17:375-400.
-
1987Monoclonal anti-HBs antibodies radioimmunoassay and serum HBV-DNA hybridization as diagnostic tools of HBV infection: relative prevalence among HBsAg-negative alcoholics, patients with chronic hepatitis or hepatocellular carcinomas and blood donors, Eur. J. Clin. Invest. 1987 Dec;17(6):515-21.
-
1987Legionnaires’ disease after bone marrow transplantation, Bone Marrow Transplant. 1987 Oct;2(3):307-13.
-
1986[Occurrence of increased alpha-fetoprotein in non-neoplastic hepatopathies of alcoholic or non-alcoholic origin], Gastroenterol. Clin. Biol. 1986 Feb;10(2):112-6.
-
1986[Malignant histiocytosis of pulmonary form], Ann Med Interne (Paris) 1986;137(7):573-5.
-
1985[Gamma-glutamyltransferase, marker of abstinence on the alcoholic cirrhotic patient?], Gastroenterol. Clin. Biol. 1985 Oct;9(10):743-4.